 This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition. [1] __NOTOC__ AACTG –acquired immunity –acquired immunodeficiency syndrome (AIDS) –AIDSinfo –ACT UP/Golden Gate –active immunity –acupuncture –acute HIV infection –Acute HIV Infection and Early Diseases Research Program (AIEDRP) –ADAP –ADC –adenopathy –adherence –adjuvant –administration –Adult AIDS Clinical Trials Group (AACTG) –adverse drug reaction –aerosolized –AETC –agammaglobulinemia –Agency for Healthcare Research and Quality (AHRQ) –AHRQ –AIDS –AIDS Arms –AIDS dementia complex (ADC) –AIDS Drug Assistance Programs (ADAP) –AIDS education and training centers (AETC) –AIDS Law Project –AIDS orphan –AIDS research advisory committee (ARAC) –AIDS service organization (ASO) –The AIDS Show –AIDS Vaccine 200 –AIDS Vaccine Advocacy Coalition –AIDS wasting syndrome –AIDS-related cancer –AIDS-related complex (ARC) –aidsdrugs –aidsline –aidstrials –alkaline phosphatase –alopecia –alpha interferon (INFa) –alternative medicine –alveolar –amebiasis –amino acids –anaphylactic shock –anemia –anergy –angiogenesis –angiomatosis –anorexia –antenatal –antibiotic –antibodies –antibody-dependent cell-mediated cytotoxicity (ADCC) –antibody-mediated immunity –antifungal medication –antigen –antigen presentation –antigen-presenting cell (APC) –antineoplastic –antiprotozoal –antiretroviral drugs –antisense drugs –antitoxins –Antiviral drug –aphasia –aphthous ulcer –apoptosis –approved drugs –ARC –Armenicum –ART –arthralgia –ASO –aspergillosis –assembly and budding –asymptomatic –ataxia –attenuated –autoantibody –autoimmunization –autoinoculation –autologous –avascular necrosis (AVN) –AVN B cell lymphoma –B cells –B lymphocytes (B cells) –bactericidal –bacteriostatic –bacterium –baculovirus –baseline –basophil –bDNA test –beta-2 microglobulin (β2M) –bilirubin –binding antibody –bioavailability –biological response modifiers (BRMs) –biopsy –biotechnology –blinded study –blips –blood–brain barrier –body fat redistribution (BFR) syndrome –body fluids – cannot drink any plain water some people?bone marrow –bone marrow suppression –booster –branched DNA assay –breakthrough infection –Broadway Cares/Equity Fights AIDS –bronchoscopy –budding –buffalo hump –bugchasing and giftgiving – Burkitt's lymphoma C-T scan (computed tomography scan) –cachexia –Canadian Foundation for AIDS Research –candida –candidiasis –carcinogen –cat scan –CCR5 –CD4 (T4) or CD4 + cells –CDC National AIDS Hotline (CDC-NAH) –CDC National Prevention Information Network (CDC-NPIN) –cell lines –cell-mediated immunity (CMI) –cellular immunity –Centers for Disease Control and Prevention (CDC) –Centers for Medicare and Medicaid Services (CMS) – central nervous system –cerebrum –cerebrospinal fluid (CSF) –cervical cancer –cervical dysplasia –cervical intraepithelial neoplasia (CIN1, CIN2, CIN3) –cervix –challenge (medicine) –chancroid –chemokines –chemoprophylaxis –chemotherapy –Chlamydia –chronic idiopathic demyelinating polyneuropathy (CIPD) –Circumoral paresthesia –clade –clinical alert –clinical endpoint –clinical latency –clinical practice guidelines –clinical trial –clinical trials information service (aidsinfo) –clinicaltrials.gov –cloning –CMS –CMV –CNS –co-receptors –coccidioidomycosis –codon –cofactors –cognitive impairment –cohort –colitis –combination therapy –community planning –Community Programs for Clinical Research on AIDS (CPCRA) –community-based clinical trial (CBCT) –community-based organization (CBO) –compassionate use –complement –complement cascade –complementary and alternative therapy –complete blood count (CBC) –computed tomography scan (C-T scan) –concomitant drugs –condyloma –condyloma acuminatum –contagious –contraindication –controlled trials –core –core protein –correlates of immunity/correlates of protection –CPCRA –creatinine –cross-resistance –cryotherapy –cryptococcal meningitis –cryptococcosis –Cryptococcus neoformans –cryptosporidiosis –Cryptosporidium –CSF –CTL –cutaneous –CXCR4 –cytokines –cytomegalovirus (CMV) –Cytomegalovirus retinitis –cytopenia –cytotoxic –cytotoxic T lymphocyte (CTL) DAIDS –data safety and monitoring board (DSMB) –deletion –dementia –demyelination –dendrite –dendritic cells –deoxyribonucleic acid (DNA) –Department of Health and Human Services (DHHS/HHS or DHHS) –desensitization –diabetes mellitus (DM) –diagnosis –diarrhea –diplopia –dissemination –division of acquired immunodeficiency syndrome (DAIDS) –DNA –Domain (biology) –dose-ranging study –dose-response relationship –double burden of disease –double-blind study –drug resistance –drug-drug interaction –DSMB –Duffy antigen system –dysplasia –dyspnea efficacy –empirical –encephalitis –end-stage disease –endemic –endogenous –endoscopy –endotoxin –endpoint –enteric –enteritis –entry inhibitors –Env –envelope –enzyme –enzyme-linked immunosorbent assay (ELISA) –eosinophil –eosinophilic folliculitis –epidemic –epidemiological surveillance –epidemiology –epithelium –epitope –Epstein-Barr virus (EBV) –erythema –erythema multiforme –erythrocytes –etiology –exclusion/inclusion criteria –exogenous –exotoxin –expanded access –experimental drug –expression system fat redistribution –FDAFDC –floaters –follicle –follicular dendritic cells (FDCs) –Food and Drug Administration (United States)functional antibody –fungus –fusin –fusion inhibitor –fusion mechanism –fusion peptide GAG –gamma globulin –gamma interferon –ganglion –GART –gastrointestinal (GI) –gene –gene therapy –genetic engineering –genital ulcer disease –genital warts –genitourinary tract –genome –genotypic assay –germinal centers –giardiasis –globulins –glycoprotein –gonorrhea –gp120 (gp120) –gp160 (gp160) –gp41 (gp41) –granulocyte –granulocyte macrophage-colony stimulating factor (GM-CSF) –granulocyte-colony stimulating factor (G-CSF) –granulocytopenia HAART –hairy leukoplakia –half-life –HAM/TSP –HCSUS –Health Care Financing Administration (HCFA) –Health Resources and Services Administration (HRSA) –HELLP syndrome –helper T cells –helper/suppressor ratio (of T cells) –hematocrit –hematotoxic –hemoglobin –hemolysis –hemophilia –hepatic –hepatic steatosis –hepatitis –hepatitis C/co-infection with HIV –hepatomegaly –herpes simplex virus 1 (HSV-1) –herpes simplex virus 2 (HSV-2) –herpes varicella zoster virus (VZV) –herpes viruses –highly active antiretroviral therapy (HAART) –histocompatibility testing –histoplasmosis –HIV Cost and Services Utilization Study (HCSUS) –HIV disease –HIV prevention trials network (HPTN) –HIV set point –HIV vaccine trials network (HVTN) –HIV-1 –HIV-2 –HIV-associated dementia –HIV-related tuberculosis –HLA –Hodgkin's disease –holistic medicine –homology (biology) –hormone –host –host factors –HPTN –HPV –HRSA –HTLV-I –HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) –HTLV-II –human growth hormone (HGH) –human immunodeficiency virus type 1 (HIV-1) –human immunodeficiency virus type 2 (HIV-2) –human leukocyte antigens (HLA) –human papilloma virus (HPV) –human T cell lymphotropic virus type I (HTLV-I) –human T cell lymphotropic virus type II (HTLV-II) –humoral immunity –HVTN –hydroxyurea –hypergammaglobulinemia –hyperglycemia –hyperlipidemia –hyperplasia –hyperthermia –hypogonadism –hypothesis –hypoxia idiopathic –idiopathic thrombocytopenia purpura –IHS –immune complex –immune deficiency/immunodeficiency –immune response –immune system –immune thrombocytopenic purpura –immunity –immunization –immunocompetent –immunocompromised –immunodeficiency –immunogen –immunogenicity –immunoglobulin (Ig) –immunoglobulin A (IgA) –immunoglobulin D (IGD) –immunoglobulin E (IGE) –immunoglobulin G (IGG) –immunoglobulin M (IGM) –immunomodulator –immunostimulant –immunosuppression –immunotherapy –immunotoxin –in vitro –in vivo –incidence –inclusion/exclusion criteria –Incubation period –IND –Indian Health Service (IHS) –infection –infectious –informed consent –infusion –inoculation –institutional review board (IRB) –integrase –integrase inhibitors –intensification –intent to treat –interaction –interferon –interleukin-1 (IL-1) –interleukin-2 (IL-2) –interleukin-4 (IL-4) –interleukin-12 (IL-12) –interleukins –International Center for Research on Women – intramuscular (IM) –intrapartum –intravenous –intravenous immunoglobulin (IVIG) –intravitreal –Investigational New Drug (IND) –IRB –ITP –IVIG jaundice –JC virus Kaposi's sarcoma (KS) –Karnofsky score –killer T cells –KSHV –Kupffer cells Langerhans cells –LAS –lentivirus –lesion –leukocytes –leukocytosis –leukopenia –leukoplakia –LFT –LIP –lipid –lipodystrophy –liposomes –live vector vaccine –liver function test (LFT) –long terminal repeat sequence (LTR) –long-term nonprogressors –LTR –lumbar –lumbar puncture –lymph –lymph nodes –lymphadenopathy syndrome (LAS) –lymphatic vessels –lymphocyte –lymphoid interstitial pneumonitis (LIP) –lymphoid organs –lymphoid tissue –lymphokine-activated killer cells (LAK) –lymphokines –lymphoma –lymphopenia –lymphoproliferative response –lysis MAC –macrophage –macrophage-tropic virus –magnetic resonance imaging (MRI) –MAI –maintenance therapy –major histocompatibility complex (MHC) –malabsorption syndrome –malaise –malignant –mast cell –MedlinePlus –mega-HAART –memory T cells –meninges –meningitis –messenger RNA –metabolism –metastasis –MHC –microbes –microbicide –Microsporidiosis –mitochondria –mitochondrial toxicity –molecule –molluscum contagiosum –monocyte –mononeuritis multiplex (MM) –monovalent vaccine –morbidity –MRI –mucocutaneous –mucosa –mucosal immunity –mucous membrane –Multicenter AIDS Cohort Study –multi-drug rescue therapy –multiple drug-resistant tuberculosis (MDR-TB) –mutation –myalgia –mycobacterium –mycobacterium avium complex (MAC) –mycosis –myelin –myelopathy –myelosuppression –myelotoxic –myocardial –myopathy NADIR –NAT –National AIDS Hotline –National Cancer Institute (NCI) –National Institute of Allergy and Infectious Diseases (NIAID) –National Institute of Child Health and Human Development (NICHD) –National Institutes of Health (NIH) –National Library of Medicine (NLM) –National Prevention Information Network (NPIN) –natural history study –natural killer cells (NK cells) –NCI –New Drug Application –nebulized –Nef –neonatal –neoplasm –nephrotoxic –neuralgia –neurological complications of AIDS –neuropathy –neutralization –neutralizing antibody –neutralizing domain –neutropenia –neutrophil –New Drug Application (NDA) –New York Cares –NIAID –NICHD –night sweat –NIH –NK cell –NLM –NNRTI –non-Hodgkin's lymphoma (NHL) –non-nucleoside reverse transcriptase inhibitors (NNRTI) –non-steroidal anti-inflammatory drugs (NSAID) –NRTI –nucleic acid –nucleic acid test –nucleocapsid –nucleoli –nucleoside –nucleoside analog –nucleoside reverse transcriptase inhibitors (NRTI) –nucleotide –nucleotide analogs –nucleus –null cell ocular –off-label use –Office of AIDS Research (OAR) –oncology –open-label trial –opportunistic infections –oral hairy leukoplakia (OHL) –organelle –oropharyngeal –orphan drugs –osteonecrosis –osteopenia P24 –package insert –palliative –palliative care –pancreas –pancreatitis –pancytopenia –pandemic –pap smear –papilloma –parallel track –parasite –parenteral –paresthesia –passive immunity –passive immunotherapy –pathogen –pathogenesis –PBMC –PCP –PCR –Pediatric AIDS Clinical Trial Group (PACTG) –pelvic inflammatory disease –peptide –perianal –perinatal –perinatal transmission –peripheral neuritis –peripheral neuropathy –persistent generalized lymphadenopathy –person with AIDS (PWA) –PGL –phagocyte –phagocytosis –pharmacokinetics –phase I trials –phase II trials –phase III trials –phase IV trials –phenotypic assay –photosensitivity –PHS –pituitary gland –placebo –placebo controlled study –placebo effect –plasma –plasma cells –platelets –PML –Pneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) –POL –polymerase –Polymerase chain reaction (PCR) –polyneuritis –polypeptide –polyvalent vaccine –post-exposure prophylaxis (PEP) –PPD test –pre-conception counseling –preclinical –precursor cells –prevalence –primary HIV infection –primary isolate –primaquine –proctitis –prodrome –prodrug –progressive multifocal leukoencephalopathy (PML) –prophylactic drug –prophylaxis –protease –protease inhibitors –protease-sparing regimen –proteins –protocol –protozoa –provirus –pruritus –pseudo-Cushing's syndrome –pseudovirion –PUBMED –pulmonary –purified protein derivative (PPD) radiology –randomized trial –rebound –receptor (immunology) –recombinant –recombinant DNA –recombinant DNA technology –refractory (medicine) –regulatory genes –regulatory T cells –remission –renal –rescue therapy –resistance –resistance testing –retina –retinal detachment –retinitis –retrovirus –REV –reverse transcriptase –ribonucleic acid (RNA) –ribosome –RNA –route of administration –RT-PCR –RTI –Ryan White C.A.R.E. act safe sex –safer sex –salmonella –salvage therapy –SAMHSA –sarcoma –seborrheic dermatitis –secondary prophylaxis –sepsis –seroconversion –serologic test –seroprevalence –serosorting –serostatus –serum –serum glutamic oxaloacetic transaminase (SGOT) –serum glutamic pyruvate transaminase (SGPT) –set point –sexually transmitted disease (STD) –shingles –SHIV –side effects –simian immunodeficiency virus (SIV) –sinusitis –social integrationSIT –SIV –Special Projects of National Significance (SPNS) –spinal tap –spleen –splenomegaly –sputum analysis –standard of care –staphylococcus –STD –stem cells (FDCs) –steroid –Stevens–Johnson syndrome –STI –stomatitis –strain –stratification –structured intermittent therapy (SIT) –structured treatment interruption (STI) –study endpoint –subarachnoid space –subclinical infection –subcutaneous (SQ) –Substance Abuse and Mental Health Services Administration (SAMHSA) –subunit HIV vaccine –sulfa drug –sulfonamides –superantigen –suppressor T cell –surrogate marker –surveillance –susceptible –symptoms –syncytium –syndrome –synergism –synergistic –synthesis –syphilis –systemic T cells (T lymphocytes) –T lymphocyte proliferation assay –T lymphocytes –T suppressor cells –T4 cell –T4 cells (T-helper cells) –T8 cells –Tanner staging –TAT –TB –template –TeachAIDS –teratogenicity –Terry Beirn Community Programs for Clinical Research on AIDS –testosterone –therapeutic HIV vaccine –thrombocytopenia –thrush –thymosin –thymus –tissue –titer –toxicity –toxoplasmic encephalitis –toxoplasmosis –transaminase –transcription –transfusion –translation –transmission –transplacental –treatment IND –triglycerides –tuberculin skin test (TST) –tuberculosis (TB) –tumor necrosis factor (TNF) V3 loop –vaccination –vaccine –vaccinia –vaginal candidiasis –valley fever –variable region –varicella zoster virus (VZV) –vector –vertical transmission –viral burden –viral core –viral culture –viral envelope –viral load –viremia –viricide –virion –virology –virus –visceral wasting syndrome –Western blot –white blood cells –wild-type virus –window period –Women's Interagency HIV Study (WIHS) –World AIDS Day –World AIDS Vaccine Day yeast infection zinc finger inhibitor –zinc fingers 
